LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_001127510.3:c.8462A>G
APC
· NP_001120982.1:p.(Asp2821Gly)
· NM_001127510.3
GRCh37: chr5:112179753 A>G
·
GRCh38: chr5:112844056 A>G
Gene:
APC
Transcript:
NM_001127510.3
Final call
Likely Benign
BS1 strong
BP1 supporting
Variant details
Gene
APC
Transcript
NM_001127510.3
Protein
NP_001120982.1:p.(Asp2821Gly)
gnomAD AF
3.1166007609492415e-05 (v4.1)
ClinVar
Likely benign
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
Likely Benign: BS1 strong is met because the APC VCEP's population-frequency threshold is exceeded.
2
Supporting BP1: the missense variant affects residue 2821, outside the APC VCEP's codon 1021-1035 exception.
Final determination:
Under Rule26 of the APC VCEP framework, one applied strong benign criterion is sufficient for a Likely Benign classification, and BS1 meets that requirement.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.8462A>G is a missense SNV, whereas APC PVS1 applies to null variants such as nonsense, frameshift, canonical splice-site, initiation-codon, or exon-deletion variants. |
pvs1_variant_assessment
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_fig_1_apc_pvs1_decision_tree_2023_10_20
|
| PS1 | Not met | Not met: p.(Asp2821Gly) affects residue 2821, outside the APC VCEP's only eligible missense PS1 positions, 1026 and 1028. |
vcep_apc_specifications_supplementary_material_v2
|
| PS2 | Not assessed | Not assessed: no proband-level de novo score, parental testing, or phenotype-point assignment is available for this variant. |
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
|
| PS3 | Not assessed | Not assessed: no variant-specific qualifying RNA assay was found, and the VCEP protein-assay pathway is limited to APC codons 959-2129 while this variant affects codon 2821. |
cspec
PMID:25741868
PMID:26580448
|
| PS4 | Not assessed | Not assessed: no variant-specific phenotype points, affected-case counts, or control comparison are available to apply the APC VCEP PS4 thresholds. |
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:26580448
|
| PM1 | N/A | Not applicable: the APC VCEP identifies no approved PM1 hotspot or critical-domain route beyond residues 1026 and 1028, while this variant is at residue 2821. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PM2 | Not met | Not met: gnomAD v2.1 non-cancer exomes show AF 0.00310% with AC 7, exceeding the APC VCEP's ≤0.0003% PM2 threshold. |
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| PM3 | N/A | Not applicable: the APC VCEP does not use PM3 because familial adenomatous polyposis has autosomal dominant inheritance. |
cspec
|
| PM4 | N/A | Not applicable: the APC VCEP states PM4 is not used due to limited available data, and this variant is a missense SNV rather than a protein-length change. |
vcep_apc_specifications_supplementary_material_v2
cspec
|
| PM5 | Not met | Not met: residue 2821 is outside the APC VCEP's PM5-eligible residues 1026 and 1028, and zero same-residue comparator candidates were identified. |
vcep_apc_specifications_supplementary_material_v2
pm5_candidates
|
| PM6 | Not assessed | Not assessed: no assumed-de-novo score, proband phenotype points, or parental-relationship evidence is available for this variant. |
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
|
| PP1 | Not assessed | Not assessed: no segregating relatives, family count, or qualifying meioses are documented for this variant. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PP2 | N/A | Not applicable: the APC VCEP marks PP2 unusable because missense variants are uncommon and usually benign, likely benign, or VUS in APC. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PP3 | Not assessed | Not assessed: SpliceAI max delta score is 0.00, but the VCEP-directed multi-predictor splice evaluation lacks a MaxEntScan result. |
cspec
vcep_apc_specifications_supplementary_material_v2
spliceai
|
| PP4 | N/A | Not applicable: the APC VCEP explicitly disallows PP4 as independent evidence because phenotype evidence is captured by PS4. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PP5 | N/A | Not applicable: the APC VCEP does not use PP5 when a reputable report lacks independently evaluable primary evidence. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| BA1 | Not met | Not met: gnomAD v2.1 non-cancer Popmax Filtering Allele Frequency is 0.017773%, below the APC VCEP's ≥0.1% BA1 threshold. |
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| BS1 | Met | Met, Strong: gnomAD v2.1 non-cancer Popmax Filtering Allele Frequency is 0.017773%, exceeding the APC VCEP's ≥0.001% BS1 threshold. |
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| BS2 | Not met | Not met: gnomAD v2.1 non-cancer exomes report zero homozygotes, and no qualifying healthy-individual phenotype points are available. |
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| BS3 | Not assessed | Not assessed: no qualifying RNA or protein assay showing preserved function was found, and the VCEP protein-assay pathway excludes this codon 2821 variant outside APC residues 959-2129. |
cspec
PMID:25741868
PMID:26580448
|
| BS4 | Not assessed | Not assessed: no affected non-carrier or qualifying phenotype-point score is documented for this variant. |
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
|
| BP1 | Met | Met at supporting: p.(Asp2821Gly) is a missense variant at residue 2821, outside the BP1 exception covering APC codons 1021-1035. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| BP2 | Not assessed | Not assessed: no documented trans phase or at least three unknown-phase observations with different (Likely) Pathogenic APC variants are available. |
cspec
|
| BP3 | N/A | Not applicable: the APC VCEP explicitly states BP3 is not used due to limited available data, and c.8462A>G is a missense SNV. |
vcep_apc_specifications_supplementary_material_v2
cspec
|
| BP4 | N/A | Not applicable: the APC VCEP explicitly excludes missense variants from BP4, and p.(Asp2821Gly) is missense. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| BP5 | Not assessed | Not assessed: no alternate pathogenic polyposis-gene variant and qualifying colorectal polyposis phenotype are documented for this case. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| BP6 | N/A | Not applicable: the APC VCEP explicitly does not use BP6 for unsupported reputable-source benign reports. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| BP7 | N/A | Not applicable: BP7 is restricted to synonymous or intronic variants, whereas c.8462A>G causes the missense change p.(Asp2821Gly). |
cspec
vcep_apc_specifications_supplementary_material_v2
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.